Efficacy of Streptokinase, but Not Tissue-Type Plasminogen Activator, in Achieving 90-Minute Patency After Thrombolysis for Acute Myocardial Infarction Decreases With Time to Treatment
Authors:
- P.GAbriel StegPSP.GAbriel Steg
- Thierry LapercheTLThierry Laperche
- Jean-Louis GolmardJGJean-Louis Golmard
- Jean-Michel JuliardJJJean-Michel Juliard
- Hakim BenamerHBHakim Benamer
- Dominique HimbertDHDominique Himbert
- Pierre AubryPAPierre Aubry
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Can We Provide Reperfusion Therapy to All Unselected Patients Admitted With Acute Myocardial Infarction?JACC, 1997
- Rearrangements of the Fibrin Network and Spatial Distribution of Fibrinolytic Components during Plasma Clot LysisJournal of Biological Chemistry, 1996
- A Study of Biochemical Markers of Reperfusion Early After Thrombolysis for Acute Myocardial InfarctionCirculation, 1995
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Angiographic monitoring of reperfusion therapy for acute myocardial infarction. TIMI grade 3 perfusion is the goal.Circulation, 1993
- Coronary Reperfusion Rates in Acute Myocardial Infarction Patients After Thrombolytic Treatment with AnistreplaseJournal of Cardiovascular Pharmacology, 1992
- Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: Controlled comparison with intracoronary streptokinaseJACC, 1988
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATIONJournal of Clinical Investigation, 1983